|
1
|
Ilic M and Ilic I: Epidemiology of
pancreatic cancer World. J Gastroenterol. 22:1–9705. 2016.
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Buscail L, Bournet B, Dufresne M,
Torrisani J and Cordelier P: Advance in the biology of pancreatic
of cancer. Bull Cancer. 102 6 Suppl 1:S53–S61. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bykov VJ and Wiman KG: Mutant p53
reactivation by small molecules makes its way to the clinic. FEBS
Lett. 588:2622–2627. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang Z, Ju H, Ling J, Zhuang Z, Li Z,
Wang H, Fleming JB, Freeman JW, Yu D, Huang P and Chiao PJ:
Cooperativity of oncogenic K-ras and downregulated p16/ink4a in
human pancreatic tumorigenesis. PLoS One. 9:e1014522014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hosotani R, Miyamoto Y, Fujimoto K, Doi R,
Otaka A, Fujii N and Imamura M: Trojan p16 peptide suppresses
pancreatic cancer growth and prolongs survival in mice. Clin Cancer
Res. 8:1271–1276. 2002.PubMed/NCBI
|
|
8
|
Kozak G, Blanco FF and Brody JR: Novel
targets in pancreatic cancer research. Semin Oncol. 42:177–187.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vilchez V, Turcios L, Marti F and Gedaly
R: Targeting Wnt/β-catenin pathway in hepatocellular carcinoma
treatment. World J Gastroenterol. 22:823–832. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
White BD, Chien AJ and Dawson DW:
Dysregulation of Wnt/β-catenin signaling in gastrointestinal
cancers. Gastroenterology. 142:219–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McCubrey JA, Rakus D, Gizak A, Steelman
LS, Abrams SL, Lertpiriyapong K, Fitzgerald TL, Yang LV, Montalto
G, Cervello M, et al: Effects of mutations in Wnt/β-catenin,
hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects
on cell growth, metabolism and cancer. Biochim Biophys Acta.
1863:2942–2976. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Froeling FE, Feig C, Chelala C, Dobson R,
Mein CE, Tuveson DA, Clevers H, Hart IR and Kocher HM: Retinoic
acid-induced pancreatic stellate cell quiescence reduces paracrine
Wnt-β-catenin signaling to slow tumor progression.
Gastroenterology. 141:1486–1497. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fargnoli MC, Gandini S, Peris K,
Maisonneuve P and Raimondi S: MC1R variants increase melanoma risk
in families with CDKN2A mutations: A meta-analysis. Eur J Cancer.
46:1413–1420. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goldstein AM, Chan M, Harland M,
Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G,
Bishop DT, Bressac-de Paillerets B, et al: High-risk melanoma
susceptibility genes and pancreatic cancer, neural system tumors,
and uveal melanoma across GenoMEL. Cancer Res. 66:9818–9828. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Badders NM, Goel S, Clark RJ, Klos KS, Kim
S, Bafico A, Lindvall C, Williams BO and Alexander CM: The Wnt
receptor, Lrp5, expressed by mouse mammary stem cells and is
required to maintain the basal lineage. PLoS One. 4:e65942009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Exner MM and Lewinski MA: Sensitivity of
multiplex real-time PCR reactions, using the LightCycler and the
ABI PRISM 7700 sequence detection system, is dependent on the
concentration of the DNA polymerase. Mol Cell Probes. 16:351–357.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kamb A: Role of a cell cycle regulator in
hereditary and sporadic cancer. Cold Spring Harb Symp Quant Biol.
59:39–47. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Holst CR, Nuovo GJ, Esteller M, Chew K,
Baylin SB, Herman JG and Tlsty TD: Methylation of p16(INK4a)
promoters occurs in vivo in histologically normal human mammary
epithelia. Cancer Res. 63:1596–1601. 2003.PubMed/NCBI
|
|
20
|
Attri J, Srinivasan R, Majumdar S, Radotra
BD and Wig J: Alterations of tumor suppressor gene p16ink4a in
pancreatic ductal carcinoma. BMC Gastroenterol. 5:222005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Whelan AJ, Bartsch D and Goodfellow PJ:
Brief report: A familial syndrome of pancreatic cancer and melanoma
with a mutation in the CDKN2a tumor-suppressor gene. N Engl J Med.
333:975–977. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Witkiewicz AK, Borja NA, Franco J, Brody
JR, Yeo CJ, Mansour J, Choti MA, McCue P and Knudsen ES: Selective
impact of CDK4/6 suppression on patient-derived models of
pancreatic cancer. Oncotarget. 6:15788–15801. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nusse R: Wnt signaling in disease and in
development. Cell Res. 15:28–32. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Cai D, Yao X, Zhang Y, Chen L, Jing
P, Wang L and Wang Y: Protective effect of ginsenoside Rg1 on
hematopoietic stem/progenitor cells through attenuating oxidative
stress and the Wnt/β-catenin signaling pathway in a mouse model of
d-galactose-induced aging. Int J Mol Sci. 17:pii: E8492016.
View Article : Google Scholar
|
|
26
|
Campaner S, Doni M, Hydbring P, Verrecchia
A, Bianchi L, Sardella D, Schleker T, Perna D, Tronnersjö S, Murga
M, et al: Cdk2 suppresses cellular senescence induced by the c-myc
oncogene. Nat Cell Biol. 12:54–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Al-Khalaf HH, Colak D, Al-Saif M,
Al-Bakheet A, Hendrayani SF, Al-Yousef N, Kaya N, Khabar KS and
Aboussekhra A: p16(INK4a) positively regulates cyclin D1 and E2F1
through negative control of AUF1. PLoS One. 6:e211112011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ray S, Atkuri KR, Deb-Basu D, Adler AS,
Chang HY, Herzenberg LA and Felsher DW: Myc can induce DNA breaks
in vivo and in vitro independent of reactive oxygen species. Cancer
Res. 66:6598–6605. 2006. View Article : Google Scholar : PubMed/NCBI
|
